{
    "organizations": [],
    "uuid": "04bff40e5887408d260e1d66dffdd51d4467e6db",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bluebird-bio-reports-q4-loss-per-s/brief-bluebird-bio-reports-q4-loss-per-share-2-52-idUSASB0C6QO",
    "ord_in_thread": 0,
    "title": "BRIEF-Bluebird Bio Reports Q4 Loss Per Share $2.52‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Bluebird Bio Inc:\n* BLUEBIRD BIO REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS\n* Q4 REVENUE $4.2 MILLION VERSUS $1.6 MILLION * ‍ENDED YEAR WITH $1.6 BILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES​\n* QTRLY LOSS PER SHARE $2.52‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T05:52:00.000+02:00",
    "crawled": "2018-02-22T17:53:20.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "bluebird",
        "bio",
        "inc",
        "bluebird",
        "bio",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "highlight",
        "operational",
        "progress",
        "q4",
        "revenue",
        "million",
        "versus",
        "million",
        "year",
        "billion",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}